TargoPep uses its next-generation peptide-based platform to design, research and refine targeted neurological delivery solutions for oligonucleotide therapeutics. Their modular and dynamic approach, combined with our mild and biocompatible attachment chemistries enables TargoPep to address these neuro-delivery needs and expand the possibilities for oligonucleotide cures into the clinic.
Take a look at the finalists across the four competition categories
Find out more